Literature DB >> 9508518

Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4.

R Troncone1, C Gianfrani, G Mazzarella, L Greco, J Guardiola, S Auricchio, P De Berardinis.   

Abstract

An abnormal mucosal cell-mediated immune response plays a fundamental role in the pathogenesis of celiac disease. To characterize locally infiltrating T cells, gliadin-specific T-cell clones were isolated from two treated celiac patients. Mucosal biopsies were cultured in vitro for 24 hr with a peptic-tryptic digest (PT) of gliadin. T-cell clones (TCC) were then isolated by limiting dilution. The production of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) was evaluated by ELISA in culture supernatants obtained after a short incubation with anti-CD3 and PMA, or with antigen. Twenty-two TCC were specific for gliadin and/or PT. All were CD3+, CD4+, CD8-, TCR alphabeta+. In one such clone the PT-specific response was inhibited by an anti-DQ, but not by an anti-DR antibody. Of the five gliadin-specific TCC examined, four produced IL-4 and high levels of IFN-gamma; the remaining one initially produced only IL-4, but subsequently also IFN-gamma. All clones obtained from the celiac mucosa, including the gliadin-specific ones, produced high levels of IFN-gamma, in most cases with IL-4. This cytokine profile could explain most of the immunological features of the celiac mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508518     DOI: 10.1023/a:1018896625699

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.

Authors:  L Maiuri; R Troncone; M Mayer; S Coletta; A Picarelli; M De Vincenzi; V Pavone; S Auricchio
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

2.  Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.

Authors:  S Fais; L Maiuri; F Pallone; M De Vincenzi; G De Ritis; R Troncone; S Auricchio
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  The effect of gluten on HLA-DR in the small intestinal epithelium of patients with coeliac disease.

Authors:  P J Ciclitira; J M Nelufer; H J Ellis; D J Evans
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

4.  Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients.

Authors:  L Maiuri; A Picarelli; M Boirivant; S Coletta; M C Mazzilli; M De Vincenzi; M Londei; S Auricchio
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

6.  Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia.

Authors:  T S Halstensen; H Scott; O Fausa; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1993-12       Impact factor: 3.487

7.  Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children.

Authors:  S Auricchio; G De Ritis; M De Vincenzi; P Occorsio; V Silano
Journal:  Pediatr Res       Date:  1982-12       Impact factor: 3.756

8.  Gluten activation of peripheral blood T cells induces a Th0-like cytokine pattern in both coeliac patients and controls.

Authors:  E M Nilsen; H A Gjertsen; K Jensen; P Brandtzaeg; K E Lundin
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

9.  Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; G A Limb; H J Ellis; P Day; P J Ciclitira
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

Review 10.  Gluten-sensitive enteropathy.

Authors:  R Troncone; L Greco; S Auricchio
Journal:  Pediatr Clin North Am       Date:  1996-04       Impact factor: 3.278

View more
  16 in total

1.  Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture.

Authors:  C Kilmartin; S Lynch; M Abuzakouk; H Wieser; C Feighery
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy.

Authors:  A D Smith; B Bagheri; R D Streilein; R P Hall
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

3.  Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease.

Authors:  M Westerholm-Ormio; J Garioch; I Ketola; E Savilahti
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

4.  Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy.

Authors:  R P Hall; A D Smith; R D Streilein
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

5.  The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.

Authors:  M Ráki; O Molberg; S Tollefsen; K E A Lundin; L M Sollid
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

6.  Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

Authors:  Michael T Bethune; Matthew Siegel; Samuel Howles-Banerji; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

7.  Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques.

Authors:  Kaushiki Mazumdar; Xavier Alvarez; Juan T Borda; Jason Dufour; Edith Martin; Michael T Bethune; Chaitan Khosla; Karol Sestak
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

8.  Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.

Authors:  Michael T Bethune; Mónica Crespo-Bosque; Elin Bergseng; Kaushiki Mazumdar; Lara Doyle; Karol Sestak; Ludvig M Sollid; Chaitan Khosla
Journal:  Chem Biol       Date:  2009-08-28

9.  Avidity progression of dietary antibodies in healthy and coeliac children.

Authors:  R Saalman; U I Dahlgren; S P Fällström; L A Hanson; S Ahlstedt; A E Wold
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

10.  Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.

Authors:  Giuseppe Mazzarella; Rosita Stefanile; Alessandra Camarca; Paolo Giliberti; Elena Cosentini; Caterina Marano; Gaetano Iaquinto; Nicola Giardullo; Salvatore Auricchio; Alessandro Sette; Riccardo Troncone; Carmen Gianfrani
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.